Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors

References

• CameronAJWelbornTAZimmetPZOverweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab)Med J Aust20031784273212720507
   PubMed Web of Science ®Google Scholar
• AmarJRuidavetsJBChamontinBAArterial stiffness and cardiovascular risk factors in a population-based studyJ Hypertens200119381711288807
   PubMed Web of Science ®Google Scholar
• BenetosARudnichiASafarMPulse pressure and cardiovascular mortality in normotensive and hypertensive subjectsHypertension19983256049740626
   PubMed Web of Science ®Google Scholar
• BlacherJGuerinAPPannierBImpact of aortic stiffness on survival in end-stage renal diseaseCirculation1999992434910318666
   PubMed Web of Science ®Google Scholar
• NakanishiNSuzukiKTataraKClustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese menAngiology200354551914565630
   PubMed Web of Science ®Google Scholar
• ChoiKMLeeKWSeoJARelationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndromeDiabet Res Clin Pract2004665761
   PubMed Web of Science ®Google Scholar
• ZiemanSJMelenovskyVKassDMechanisms, pathophysiology, and therapy of arterial stiffnessArterioscler Thromb Vasc Biol2005259324315731494
   PubMed Web of Science ®Google Scholar
• KoivistoinenTKbiTJulaAPulse wave velocity reference values in healthy adults aged 26–75 yearsClin Physiol Funct Imag2007271916
   PubMed Web of Science ®Google Scholar
• LundbergJOWeitzbergEGladwinMTThe nitrate-nitrite-nitric oxide pathway in physiology and therapeuticsNature Rev Drug Discov200871566718167491
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMBlochKDThe vascular biology of nitric oxide and its role in atherogenesisAnnu Rev Med199647365758712788
   PubMed Web of Science ®Google Scholar
• VehkavaaraSGroopPHSeppala-LindroosAIn vivo endothelial dysfunction characterizes patients with impaired fasting glucoseDiabet Care199922205560
   PubMed Web of Science ®Google Scholar
• AvogaroAPiarulliFValerioAForearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patientsDiabetes199746104069166677
   PubMed Web of Science ®Google Scholar
• GoodfellowJRamseyMLuddingtonLAEndothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetesBr Med J199631274458605460
   PubMed Web of Science ®Google Scholar
• ChowienczykPJKellyRPMacCallumHPhotoplethys-mographic assessment of pulse wave reflection: Blunted response to endothelium-dependent beta2-adrenergic vasodilatation in type 2 diabetes mellitusJ Am Coll Cardiol19993420071410588217
   PubMed Web of Science ®Google Scholar
• DarkoDDornhorstAKellyFJLack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetesClin Sci20021033394412241530
   PubMed Web of Science ®Google Scholar
• IBWilkinsonQasemAMcEnieryCMNitric oxide regulates local arterial distensibility in vivoCirculation2002105213711790703
   PubMed Web of Science ®Google Scholar
• WilkinsonIBFranklinSCockcroftJRNitric oxide and the regulation of large artery stiffness: from physiology to pharmacologyHypertension200444112615262901
   PubMed Web of Science ®Google Scholar
• ChoiKMLeeKWSeoJARelationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndromeDiabet Res Clin Pract2004665761
   PubMed Web of Science ®Google Scholar
• LacyPSO’BrienDGStanleyAGIncreased pulse wave velocity is not associated with elevated augmentation index inpatients with diabetesJ Hypertens20042219374415361765
   PubMed Web of Science ®Google Scholar
• KostensePJHenryRMSpijkermanAArterial stiffness increases with deteriorating glucose tolerance status: The Hoorn StudyCirculation20031620899512695300
   PubMedGoogle Scholar
• CzernichowSBertraisSBlacherJMetabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure: a report from the SU.VI.MAX. Vascular StudyAm J Hypertens20051811546016182103
   PubMed Web of Science ®Google Scholar
• SalomaaRWVKarkJDNardoCArterial disease/hypertension/angiotensin system: non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: The ARIC StudyCirculation1995911432437867184
   PubMed Web of Science ®Google Scholar
• GiannattasioCMangoniAAFaillaMImpaired radial artery compliance in normotensive subjects with familial hypercholesterolaemiaAtherosclerosis1996124249608830937
   PubMed Web of Science ®Google Scholar
• HuJWallensteenMGennserGIncreased stiffness of the aorta in children and adolescents with insulin-dependent diabetes mellitusUltrasound Med Biol199622537438865550
   PubMed Web of Science ®Google Scholar
• BerryKLSkyrme-JonesAPCameronJDSystemic arterial compliance is reduced in young patients with IDDMAm J Physiol1999276H1839H4510362661
   PubMedGoogle Scholar
• MangoniAAGiannattasioCBrunaniARadial artery compliance in young, obese, normotensive subjectsHypertension19952698487490159
   PubMed Web of Science ®Google Scholar
• LaurentSHayozDTrazziSIsobaric compliance of the radial artery is increased in patients with essential hypertensionJ Hypertens19931189988382244
   PubMed Web of Science ®Google Scholar
• BrillanteDGO’SullivanAJJohnstoneMTArterial stiffness and haemodynamic response to vasoactive medication in subjects with insulin-resistance syndromeClin Sci20081141394717685897
   PubMed Web of Science ®Google Scholar
• MaejimaKNakanoSHimenoMIncreased basal levels of plasma nitric oxide in type 2 diabetic subjects. Relationship to micro-vascular complicationsJ Diabet Complicat20011513543
   Google Scholar
• WoodmanRJPlayfordDAWattsGFBasal production of nitric oxide (NO) and non-NO vasodilators in the forearm circulation in type 2 diabetes: Associations with blood pressure and HDL cholesterolDiabet Res Clin Pract2006715967
   PubMed Web of Science ®Google Scholar
• GraierWFWascherTCLachnerLExposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory responseDiabetes19934214975058375590
   PubMed Web of Science ®Google Scholar
• HowesLGReview: The effects of lipid lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patientsDiabet Obes Metabol20068814
   PubMed Web of Science ®Google Scholar
• JensenTFeldt-RasmussenBBjerre-KnudsenJFeatures of endothelial dysfunction in early diabetic nephropathyLancet198933346132563840
   PubMedGoogle Scholar
• ElliottTGCockcroftJRGroopPHInhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuriaClin Sci199385687938287660
   PubMed Web of Science ®Google Scholar
• WascherTCGraierWFBahadoriBTime course of endothelial dysfunction in diabetes mellitusCirculation1994901109108044928
   PubMed Web of Science ®Google Scholar
• CernesRZimlichmanRShargorodskyMArterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetesAdv Cardio456581
   PubMedGoogle Scholar
• The ONTARGET InvestigatorsTelmisartan, ramipril, or both in patients at high risk for vascular eventsN Eng J Med2008358154759
   PubMed Web of Science ®Google Scholar
• The HOPE Study InvestigatorsEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Eng J Med200034214553
   PubMed Web of Science ®Google Scholar
• The SOLVD InvestigatorsEffect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureN Eng J Med1991325293302
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Eng J Med20013458619
   PubMed Web of Science ®Google Scholar
• NeldamSMogensenCETikkanenIRandomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyBr Med J20003211440411110735
   PubMedGoogle Scholar
• StehouwerCDAHenryRMAFerreiraIArterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular diseaseDiabetologia2008515273918239908
   PubMed Web of Science ®Google Scholar
• YanCKimDAizawaTFunctional interplay between angiotensin II and nitric oxide: cyclic GMP as key mediatorArterioscler Thromb Vasc Biol200323263612524221
   PubMed Web of Science ®Google Scholar
• FordCMLiSPickeringJGAngiotensin II stimulates collagen synthesis in human vascular smooth muscle cells: involvement of the AT1 receptor, transforming growth factor-beta, and tyrosine phosphorylationArterioscler Thromb Vasc Biol19991918435110446062
   PubMed Web of Science ®Google Scholar
• WatanabeTBarkerTABerkBCAngiotensin II and the endothelium: diverse signals and effectsHypertension200545163915630047
   PubMed Web of Science ®Google Scholar
• IgarashiMHirataANozakiHRole of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic ratsDiabet Res Clin Pract20077526777
   PubMed Web of Science ®Google Scholar
• VolpeMMusumeciBDe PaolisPAngiotensin II AT2 receptor subtype: An uprising frontier in cardiovascular diseaseHypertension200321142943
   Web of Science ®Google Scholar
• BarkerTAMassettMPKorshunovVAAngiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockadeHypertension200648942916982965
   PubMed Web of Science ®Google Scholar
• YayamaKHiyoshiHImazuDAngiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptorHypertension2006489586417000928
   PubMed Web of Science ®Google Scholar
• BlumeAKaschinaEUngerTAngiotensin II type 2 receptors: Signalling and pathophysiological roleCurr Opin Nephrol Hyperten20011023946
   PubMed Web of Science ®Google Scholar
• De GasparoMCattKJInagamiTInternational union of pharmacology XXIII. The angiotensin II receptorsPharmacol Rev2000524157210977869
   PubMed Web of Science ®Google Scholar
• DeanRCaoZWuLRole of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophyHypertension1999344081410489386
   PubMed Web of Science ®Google Scholar
• BrillanteDGJohnstoneMTHowesLGEffects of intravenous PD123319 on haemodynamic and arterial stiffness indices in healthy volunteersJ Renin Angiotens Aldo Syst200561026
   PubMed Web of Science ®Google Scholar
• BrillanteDGO’SullivanAJJohnstoneMTEvidence for functional expression of vascular AT2 receptors in patients with insulin resistanceDiabet Obes Metab20081014350
   PubMed Web of Science ®Google Scholar
• KimSGRyuOHKimHYEffect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with pre-diabetes or non-diabetic metabolic syndromeEur J Endocrinol20061544334016498057
   PubMed Web of Science ®Google Scholar
• WeidmannPBeretta-PiccoliCTrostBNPressor factors and responsiveness in hypertension accompanying diabetes mellitusHypertension19857(6 Pt 2)I13342
   Web of Science ®Google Scholar
• CareyRMJinXHWangZQNitric oxide: A physiological mediator of the type 2 (AT2) angiotensin receptorActa Physiol Scand2000168657110691781
   PubMedGoogle Scholar
• WoodmanRJDoes compensatory nitric oxide and angiotensin II receptor activity reduce arterial stiffness in early-stage insulin resistanceClin Sci20081141192117880282
   PubMed Web of Science ®Google Scholar
• SavioaCTouyzRMVolpeMAngiotensin Type 2 Receptor in resistance arteries of type 2 diabetic hypertensive patientsHypertension200749341617159079
   PubMed Web of Science ®Google Scholar